Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery

Overview of attention for article published in Discover Nano, January 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 32 publications that cite this research output.

32

The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.

Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction

Article in Archiv der Pharmazie (December 2023)

Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells

Article in Journal of Chemotherapy (October 2023)

Sorafenib-Based Drug Delivery Systems: Applications and Perspectives

Article in Polymers (June 2023)